PMV Pharmaceuticals
CRANBURY, NJ · Founded 2013 · CIK 0001699382 · Biotech · Public
Small molecule p53 regulators for cancer treatment
pmvpharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $74M
- 1 Form D · Mar 2017
- 115 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 12 granted · 28 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $73,728,198 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2223 | Alloy Therapeutics | — | $147M |
| 2224 | ArriVent Biopharma | — | $191M |
| 2225 | MOBIUS SCIENTIFIC INC. | — | — |
| 2226 | PMV Pharmaceuticals | — | $74M |
| 2227 | FibroBiologics, LLC | — | $11M |
| 2228 | Diagonal Therapeutics | — | — |
| 2229 | Nimbus Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Arnold LevineDirector
- David MackDirector · Executive Officer
- Arnold OronskyDirector
- Peter ThompsonDirector
- Steve WinickDirector
Patents
- METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONapplication
- Uses Of P53 X-ray Co-crystal Structuresgranted
- Combination Therapy For Treatment Of Cancerapplication
- METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONapplication
- Methods And Compounds For Restoring Mutant P53 Functionapplication
- METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONgranted
- Companion Diagnostic Tool For Mutant P53 Reactivating Compoundsgranted
- DEUTERATED COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONapplication
- Combination Therapy For Treatment Of Cancerapplication
- DEUTERATED COMPOUNDS FOR RESTORING MUTANT p53 FUNCTIONgranted
- Heterocycles as WIP1 Inhibitorsapplication
- MDM2 Inhibitors And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.